• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过体外数据预测体内II期葡萄糖醛酸化代谢的挑战与机遇

Challenges and Opportunities with Predicting in Vivo Phase II Metabolism via Glucuronidation from in Vitro Data.

作者信息

Ge Shufan, Tu Yifan, Hu Ming

机构信息

Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, The University of Houston, 1441 Moursund Street, Houston, TX, 77030, USA.

出版信息

Curr Pharmacol Rep. 2016 Dec;2(6):326-338. doi: 10.1007/s40495-016-0076-8. Epub 2016 Nov 8.

DOI:10.1007/s40495-016-0076-8
PMID:28966903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5613675/
Abstract

Glucuronidation is the most important phase II metabolic pathway which is responsible for the clearance of many endogenous and exogenous compounds. To better understand the elimination process for compounds undergoing glucuronidation and identify compounds with desirable in vivo pharmacokinetic properties, many efforts have been made to predict glucuronidation using data. In this article, we reviewed typical approaches used in previous predictions. The problems and challenges in prediction of glucuronidation were discussed. Besides that different incubation conditions can affect the prediction accuracy, other factors including efflux / uptake transporters, enterohepatic recycling, and deglucuronidation reactions also contribute to the disposition of glucuronides and make the prediction more difficult. PBPK modeling, which can describe more complicated process , is a promising prediction strategy which may greatly improve the prediction of glucuronidation and potential DDIs involving glucuronidation. Based on previous studies, we proposed a transport-glucuronidation classification system, which was built based on the kinetics of both glucuronidation and transport of the glucuronide. This system could be a very useful tool to achieve better predictions.

摘要

葡萄糖醛酸化是最重要的Ⅱ相代谢途径,负责清除许多内源性和外源性化合物。为了更好地理解经历葡萄糖醛酸化的化合物的消除过程,并识别具有理想体内药代动力学性质的化合物,人们已做出诸多努力利用数据预测葡萄糖醛酸化。在本文中,我们回顾了先前预测中使用的典型方法。讨论了葡萄糖醛酸化预测中的问题和挑战。除了不同的孵育条件会影响预测准确性外,其他因素包括外排/摄取转运体、肠肝循环和去葡萄糖醛酸化反应也会影响葡萄糖醛酸苷的处置,使预测更加困难。生理药代动力学(PBPK)建模能够描述更复杂的过程,是一种很有前景的预测策略,可能会极大地改善葡萄糖醛酸化及涉及葡萄糖醛酸化的潜在药物相互作用的预测。基于先前的研究,我们提出了一种转运-葡萄糖醛酸化分类系统,该系统基于葡萄糖醛酸化和葡萄糖醛酸苷转运的动力学构建。该系统可能是实现更好预测的非常有用的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf9/5613675/fb1d4dc59201/nihms-828623-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf9/5613675/c7556d44ce9a/nihms-828623-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf9/5613675/273618e907ba/nihms-828623-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf9/5613675/fb1d4dc59201/nihms-828623-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf9/5613675/c7556d44ce9a/nihms-828623-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf9/5613675/273618e907ba/nihms-828623-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf9/5613675/fb1d4dc59201/nihms-828623-f0003.jpg

相似文献

1
Challenges and Opportunities with Predicting in Vivo Phase II Metabolism via Glucuronidation from in Vitro Data.通过体外数据预测体内II期葡萄糖醛酸化代谢的挑战与机遇
Curr Pharmacol Rep. 2016 Dec;2(6):326-338. doi: 10.1007/s40495-016-0076-8. Epub 2016 Nov 8.
2
Transport-Glucuronidation Classification System and PBPK Modeling: New Approach To Predict the Impact of Transporters on Disposition of Glucuronides.转运体-葡萄糖醛酸结合分类系统和 PBPK 建模:预测转运体对葡萄糖醛酸缀合物处置影响的新方法。
Mol Pharm. 2017 Sep 5;14(9):2884-2898. doi: 10.1021/acs.molpharmaceut.6b00941. Epub 2017 Mar 13.
3
Decreased Expression of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) Leads to Reduced Glucuronidation of Flavonoids in UGT1A1-Overexpressing HeLa Cells: The Role of Futile Recycling.多药耐药相关蛋白4(MRP4/ABCC4)表达降低导致UGT1A1过表达的HeLa细胞中黄酮类化合物葡萄糖醛酸化减少:无效循环的作用
J Agric Food Chem. 2015 Jul 8;63(26):6001-8. doi: 10.1021/acs.jafc.5b00983. Epub 2015 Jun 22.
4
Interplay of Efflux Transporters with Glucuronidation and Its Impact on Subcellular Aglycone and Glucuronide Disposition: A Case Study with Kaempferol.外排转运体与葡萄糖醛酸化的相互作用及其对细胞内苷元和葡萄糖醛酸缀合物处置的影响:以山奈酚为例的研究。
Mol Pharm. 2018 Dec 3;15(12):5602-5614. doi: 10.1021/acs.molpharmaceut.8b00782. Epub 2018 Nov 9.
5
Stable knock-down of efflux transporters leads to reduced glucuronidation in UGT1A1-overexpressing HeLa cells: the evidence for glucuronidation-transport interplay.外排转运体的稳定敲低导致UGT1A1过表达的HeLa细胞中葡萄糖醛酸化作用减弱:葡萄糖醛酸化-转运相互作用的证据
Mol Pharm. 2015 Apr 6;12(4):1268-78. doi: 10.1021/mp5008019. Epub 2015 Mar 11.
6
Quantitative prediction of glucuronidation in humans using the in vitro- in vivo extrapolation approach.应用体外-体内外推法对人体葡萄糖醛酸化进行定量预测。
Curr Top Med Chem. 2013;13(11):1343-52. doi: 10.2174/15680266113139990038.
7
In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance.人药物葡萄糖醛酸化的体外分析及体内代谢清除率的预测
J Pharmacol Exp Ther. 2002 Apr;301(1):382-90. doi: 10.1124/jpet.301.1.382.
8
Use of physiologically based pharmacokinetic models to evaluate the impact of intestinal glucuronide hydrolysis on the pharmacokinetics of aglycone.利用基于生理学的药代动力学模型评估肠内葡萄糖醛酸水解对苷元药代动力学的影响。
J Pharm Sci. 2012 Mar;101(3):1281-301. doi: 10.1002/jps.22827. Epub 2011 Nov 22.
9
Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides.化学抑制和稳定敲低外排转运蛋白可减少 UGT1A1 过表达 HeLa 细胞中吴山茱萸新橙皮苷的葡萄糖醛酸化:乳腺癌耐药蛋白(BCRP)和多药耐药相关蛋白(MRPs)在葡萄糖醛酸缀合物排泄中的作用。
Food Funct. 2018 Mar 1;9(3):1410-1423. doi: 10.1039/c7fo01298e. Epub 2018 Jan 10.
10
Dealing with the complex drug-drug interactions: towards mechanistic models.应对复杂的药物相互作用:迈向机制模型。
Biopharm Drug Dispos. 2015 Mar;36(2):71-92. doi: 10.1002/bdd.1934. Epub 2015 Feb 10.

引用本文的文献

1
Untargeted MS-Based Monitoring of Glucuronides in Fish: Screening Complex Mixtures for Contaminants with Biological Relevance.基于非靶向质谱法对鱼类中葡萄糖醛酸苷的监测:筛选具有生物学相关性的复杂污染物混合物。
ACS ES T Water. 2022 Dec 9;2(12):2481-2490. doi: 10.1021/acsestwater.2c00310.
2
In Silico Analyses of a Promising Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis Targeting Superoxide Dismutase I Protein.针对超氧化物歧化酶I蛋白治疗肌萎缩侧索硬化症的一种有前景的候选药物的计算机模拟分析
Pharmaceutics. 2023 Mar 29;15(4):1095. doi: 10.3390/pharmaceutics15041095.
3
Defining the Role of GLI/Hedgehog Signaling in Chemoresistance: Implications in Therapeutic Approaches.

本文引用的文献

1
Metabolite Kinetics: The Segregated Flow Model for Intestinal and Whole Body Physiologically Based Pharmacokinetic Modeling to Describe Intestinal and Hepatic Glucuronidation of Morphine in Rats In Vivo.代谢物动力学:用于肠道和全身基于生理的药代动力学建模的分离流模型,以描述大鼠体内吗啡的肠道和肝脏葡萄糖醛酸化。
Drug Metab Dispos. 2016 Jul;44(7):1123-38. doi: 10.1124/dmd.116.069542. Epub 2016 Apr 20.
2
Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice.索拉非尼的代谢、转运及肠肝循环:基于生理学的小鼠模型构建与模拟
Cancer Chemother Pharmacol. 2016 May;77(5):1039-52. doi: 10.1007/s00280-016-3018-6. Epub 2016 Apr 6.
3
定义GLI/刺猬信号通路在化疗耐药中的作用:对治疗方法的启示
Cancers (Basel). 2021 Sep 23;13(19):4746. doi: 10.3390/cancers13194746.
4
PBPK Modeling as a Tool for Predicting and Understanding Intestinal Metabolism of Uridine 5'-Diphospho-glucuronosyltransferase Substrates.基于生理药代动力学(PBPK)模型预测和理解尿苷5'-二磷酸葡萄糖醛酸转移酶底物肠道代谢的工具
Pharmaceutics. 2021 Aug 24;13(9):1325. doi: 10.3390/pharmaceutics13091325.
5
Racial Disparity in Drug Disposition in the Digestive Tract.种族差异对消化道药物处置的影响。
Int J Mol Sci. 2021 Jan 21;22(3):1038. doi: 10.3390/ijms22031038.
6
Novel testing strategy for prediction of rat biliary excretion of intravenously administered estradiol-17β glucuronide.新型检测策略预测静脉给予雌二醇-17β-葡糖苷酸在大鼠胆汁中的排泄。
Arch Toxicol. 2021 Jan;95(1):91-102. doi: 10.1007/s00204-020-02908-x. Epub 2020 Nov 7.
7
Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview.伊立替康——癌症化疗中的重要角色:全面概述。
Int J Mol Sci. 2020 Jul 12;21(14):4919. doi: 10.3390/ijms21144919.
8
Synthesis, Anticancer Activity, and Preliminary Pharmacokinetic Evaluation of 4,4-Disubstituted Curcuminoid 2,2-bis(Hydroxymethyl)Propionate Derivatives.4,4-二取代姜黄素 2,2-双(羟甲基)丙酸酯衍生物的合成、抗癌活性及初步药代动力学评价。
Molecules. 2020 Jan 22;25(3):479. doi: 10.3390/molecules25030479.
9
Evaluation of Clinically Relevant Drug-Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial.评估非转移性去势抵抗性前列腺癌患者达罗他胺的临床相关药物-药物相互作用和群体药代动力学:III 期ARAMIS 试验的预设和事后分析结果。
Target Oncol. 2019 Oct;14(5):527-539. doi: 10.1007/s11523-019-00674-0.
10
Synthesis and Preclinical Evaluation of the First Carbon-11 Labeled PET Tracers Targeting Substance P.合成及首例碳-11 标记正电子发射断层扫描(PET)示踪剂靶向物质 P 的临床前评估。
Mol Pharm. 2018 Nov 5;15(11):4872-4883. doi: 10.1021/acs.molpharmaceut.8b00518. Epub 2018 Oct 25.
Disposition of flavonoids via recycling: Direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides.
通过循环对黄酮类化合物的处置:肠道或肝外来源的黄酮类葡萄糖醛酸苷的直接胆汁排泄。
Mol Nutr Food Res. 2016 May;60(5):1006-19. doi: 10.1002/mnfr.201500692. Epub 2016 Apr 13.
4
The role of glucuronidation in drug resistance.葡萄糖醛酸化在耐药性中的作用。
Pharmacol Ther. 2016 Mar;159:35-55. doi: 10.1016/j.pharmthera.2016.01.009. Epub 2016 Jan 22.
5
Diclofenac and Its Acyl Glucuronide: Determination of In Vivo Exposure in Human Subjects and Characterization as Human Drug Transporter Substrates In Vitro.双氯芬酸及其酰基葡萄糖醛酸苷:人体受试者体内暴露量的测定及体外作为人类药物转运体底物的表征
Drug Metab Dispos. 2016 Mar;44(3):320-8. doi: 10.1124/dmd.115.066944. Epub 2015 Dec 29.
6
Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP.姜黄素通过抑制外排转运体MRP2和BCRP影响白藜芦醇的Ⅱ相代谢。
Pharm Res. 2016 Mar;33(3):590-602. doi: 10.1007/s11095-015-1812-1. Epub 2015 Oct 26.
7
Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-Glucuronide.吉非贝齐及其主要代谢物吉非贝齐1-O-β-葡萄糖醛酸苷的肝脏处置
Mol Pharm. 2015 Nov 2;12(11):3943-52. doi: 10.1021/acs.molpharmaceut.5b00411. Epub 2015 Sep 30.
8
Decreased Expression of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) Leads to Reduced Glucuronidation of Flavonoids in UGT1A1-Overexpressing HeLa Cells: The Role of Futile Recycling.多药耐药相关蛋白4(MRP4/ABCC4)表达降低导致UGT1A1过表达的HeLa细胞中黄酮类化合物葡萄糖醛酸化减少:无效循环的作用
J Agric Food Chem. 2015 Jul 8;63(26):6001-8. doi: 10.1021/acs.jafc.5b00983. Epub 2015 Jun 22.
9
Modeling approach for multiple transporters-mediated drug-drug interactions in sandwich-cultured human hepatocytes: effect of cyclosporin A on hepatic disposition of mycophenolic acid phenyl-glucuronide.三明治培养的人肝细胞中多种转运体介导的药物-药物相互作用的建模方法:环孢素A对麦考酚酸苯葡糖苷肝处置的影响
Drug Metab Pharmacokinet. 2015 Apr;30(2):142-8. doi: 10.1016/j.dmpk.2014.10.006. Epub 2014 Nov 14.
10
Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1b.索拉非尼葡糖醛酸的肝细胞穿梭和再循环依赖于Abcc2、Abcc3和Oatp1a/1b。
Cancer Res. 2015 Jul 1;75(13):2729-36. doi: 10.1158/0008-5472.CAN-15-0280. Epub 2015 May 7.